Ingrain debuts 3D NanoXCT imaging system for molecular imaging

Ingrain, a rock physics company, has introduced its NanoXCT imaging device that can reveal nano-scale, 3D imaging for non-destructive, non-invasive investigations in a range of scientific applications, including drug discovery and molecular imaging.

The 3D NanoXCT is capable of focusing an x-ray source onto a small region of interest within a rock sample—as small as 20-60 microns. The best resolution of the new device is 0.05 microns (50 nanometers), the company said.

The Houston-based Ingrain said its NanoXCT creates multiple views of a rock sample by focusing its x-ray source through a condensing lens on a particular region of interest. The x-rays exit the object and pass through a device that focuses the beam onto a detector to form each view. The views are combined to create a virtual, 3D image, the company said.

 

Around the web

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.